(S)-N-(2-amino-2-oxoethyl)-N-(2,4-dichlorophenethyl)-2-(4-(2,4-dichlorophenethyl)-1-(3,3-diphenylpropyl)-3,6-dioxopiperazin-2-yl)acetamide

ID: ALA2203812

PubChem CID: 71459413

Max Phase: Preclinical

Molecular Formula: C39H38Cl4N4O4

Molecular Weight: 768.57

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  NC(=O)CN(CCc1ccc(Cl)cc1Cl)C(=O)C[C@H]1C(=O)N(CCc2ccc(Cl)cc2Cl)CC(=O)N1CCC(c1ccccc1)c1ccccc1

Standard InChI:  InChI=1S/C39H38Cl4N4O4/c40-30-13-11-28(33(42)21-30)15-18-45(24-36(44)48)37(49)23-35-39(51)46(19-16-29-12-14-31(41)22-34(29)43)25-38(50)47(35)20-17-32(26-7-3-1-4-8-26)27-9-5-2-6-10-27/h1-14,21-22,32,35H,15-20,23-25H2,(H2,44,48)/t35-/m0/s1

Standard InChI Key:  SMGIHWYGEYMISR-DHUJRADRSA-N

Molfile:  

     RDKit          2D

 51 55  0  0  0  0  0  0  0  0999 V2000
   12.4009   -7.1524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3998   -7.9720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1078   -8.3810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8175   -7.9715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8146   -7.1489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1060   -6.7436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1076   -9.1981    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   11.6931   -6.7440    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   13.1036   -5.9264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8101   -5.5157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8076   -4.6985    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.5141   -4.2878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0987   -4.2920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3922   -4.7027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6833   -4.2963    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.3947   -5.5199    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.5117   -3.4706    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.2230   -4.6943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9295   -4.2836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6374   -4.6949    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.3417   -4.2877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3435   -3.4701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6348   -3.0615    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.9242   -3.4704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2154   -3.0636    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.0491   -4.6968    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.6351   -2.2443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3430   -1.8360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3433   -1.0188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0508   -0.6147    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0515    0.2028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3434    0.6185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6332    0.2057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6360   -0.6164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3427    1.4357    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   15.9303   -1.0284    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   16.6365   -5.5121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3437   -5.9215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3428   -6.7387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0500   -7.1481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6346   -7.1465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9307   -6.7337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2231   -7.1408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2217   -7.9589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9339   -8.3681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6387   -7.9586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0447   -7.9625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7511   -8.3718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4603   -7.9639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4586   -7.1425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7516   -6.7369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  3  7  1  0
  1  8  1  0
  6  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 12 17  2  0
 12 18  1  0
 19 18  1  1
 19 20  1  0
 19 24  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 21 26  2  0
 23 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 32 35  1  0
 34 36  1  0
 20 37  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 39 41  1  0
 41 42  2  0
 42 43  1  0
 43 44  2  0
 44 45  1  0
 45 46  2  0
 46 41  1  0
 40 47  2  0
 47 48  1  0
 48 49  2  0
 49 50  1  0
 50 51  2  0
 51 40  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA2203812

   N-(2-amino-2-oxoethyl)-N-[2-(2,4-dichlorophenyl)ethyl]-2-[(2S)-4-[2-(2,4-dichlorophenyl)ethyl]-1-(3,3-diphenylpropyl)-3,6-dioxopiperazin-2-yl]acetamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 768.57

Molecular Weight (Monoisotopic): 766.1647

AlogP: 7.05

#Rotatable Bonds: 15

Polar Surface Area: 104.02

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: 2

HBA (Lipinski): 8

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 2

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: 6.80

CX LogD: 6.80

Aromatic Rings: 4

Heavy Atoms: 51

QED Weighted: 0.14

Np Likeness Score: -0.86

References

1. Moure A, Orzáez M, Sancho M, Messeguer A..  (2012)  Synthesis of enantiomerically pure perhydro-1,4-diazepine-2,5-dione and 1,4-piperazine-2,5-dione derivatives exhibiting potent activity as apoptosis inhibitors.,  22  (23): [PMID:23079529] [10.1016/j.bmcl.2012.09.078]

Source

Source(1):

• Scientific Literature